info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » pharmaceuticals

pharmaceuticals

Collagen Skin Matrix Market By Product Type (Acellular Dermal Matrices, Cellular Matrices, Hybrid/Composite Matrices); By Application (Chronic Wounds, Burns and Trauma, Surgical Reconstruction, Aesthetic Dermatology); By End User (Hospitals, Wound Care Centers, Specialty Clinics, Aesthetic Dermatology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Collagen Skin Matrix Market is projected to witness a robust CAGR of 8.1%, valued at around USD 3.2 billion in 2024 and expected to reach... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Botanical and Plant-Derived Drugs Market By Drug Type (Purified Compounds, Standardized Botanical Combinations, Complex Phytopharmaceuticals); By Application (Oncology, Cardiovascular, Metabolic, Immune-Related, Neuropsychiatric Disorders); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Botanical And Plant-Derived Drugs Market will experience a steady CAGR of 6.5 % , valued at about 34.7 billion US dollars in 2024... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Antipruritic Market By Product Type (Topical Agents, Oral Medications, Injectables, Biologics); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antipruritic Market is projected to achieve steady expansion from 2024 to 2030, with a CAGR of 5.8%. Market value is estimated at 7.6 billion dollars in 2024, and forecast... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Dental Anesthesia Market By Product Type (Local Anesthetics, General Anesthetics, Sedatives & Adjuncts); By Delivery System (Injectable Systems, Topical Anesthesia, Computer-Controlled Delivery, Needle-Free Systems); By Application (Restorative Dentistry, Endodontics & Periodontics, Oral Surgery, Cosmetic Dentistry); By End User (General Dental Clinics, Pediatric Dentistry Practices, Oral Surgery Centers, Hospitals & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dental Anesthesia Market will witness a steady CAGR of 5.9%, valued at USD 2.3 billion in 2024, expected to reach nearly... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Cognitive and Memory Enhancer Drugs Market By Product Type (Prescription Drugs, OTC Supplements); By Route of Administration (Oral, Injectable, Transdermal); By End User (Hospitals, Specialty Clinics, Diagnostic Centers, Retail Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cognitive And Memory Enhancer Drugs Market is projected to witness a robust CAGR of 9.1%, valued at Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Obesity GLP-1 Market By Product Type (Monotherapy GLP-1, Dual/Triple Agonists); By Route of Administration (Injectable, Oral, Implantable); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies, DTC/Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Obesity GLP-1 Market is poised for accelerated growth between 2024 and 2030, climbing from a valuation of USD 15.7 billion in 2024 to USD 42.1 bil... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Barbiturate Drugs Market By Drug Formulation (Short-Acting Barbiturates, Long-Acting Barbiturates); By Therapeutic Application (Epilepsy, Anesthesia Induction, Migraine Combination Therapy, Veterinary Sedation and Euthanasia); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Government Programs, Veterinary Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Barbiturate Drugs Market will grow at an CAGR of 4.8%, valued at USD 412 million in 2024 and projected to reach around USD 547 million by 2030, according ... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Injectable Nanomedicine Market By Nanocarrier Type (Liposomes, Polymeric Nanoparticles, Micelles, Dendrimers, Metallic Nanoparticles); By Application (Oncology, Cardiovascular, Neurology, Autoimmune Diseases, Infectious Diseases); By End User (Specialty Clinics, Academic Medical Centers, CROs, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Injectable Nanomedicine Market is projected to expand at a robust CAGR of 9.4%, reaching an estimated USD 96.3 billion by 2030, up from USD 54.9 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Pharmaceutical Intermediates Market By Product Type (Primary Intermediates, Secondary Intermediates, Specialty Intermediates); By Application (Oncology, Cardiovascular, Anti-Infective, Neurology, Others); By End User (Branded Pharmaceutical Manufacturers, Generic Drug Manufacturers, CMOs, Emerging Biopharmaceutical Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Intermediates Market is set to witness a robust growth trajectory, with an estimated market size of USD 62.3 billion in 2024, projected to reach USD 92.7 billion by ... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Sugar-Based Excipients Market By Product Type (Sucrose, Mannitol, Sorbitol, Isomalt, Others); By Functionality (Binders, Fillers, Diluents, Flavoring Agents); By Application (Pharmaceuticals, Nutraceuticals, Food & Beverage, Veterinary); By End User (Pharmaceutical Companies, Generic Manufacturers, Nutraceutical Brands, Contract Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sugar-Based Excipients Market is projected to reach well beyond the USD 1.4 billion mark by 2030, rising from an estimated USD 900 million in 2024. Growth is steady, runni... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Pharmaceutical Grade Sodium Chloride Market By Form (Powdered Crystalline, Solution – Injection-Ready); By Application (Parenteral/IV, Dialysis, Oral/Nasal Therapeutics); By End User (Pharmaceutical Companies, Hospitals, Dialysis Centers, Contract Manufacturing Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Grade Sodium Chloride Market is poised for stable expansion from 2024 to 2030, driven by regulatory tightening, injectable drug formulation demand, and cross-sector reliance on sterile salin... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Performance Enhancing Drugs Market By Product Type (Anabolic Agents, Peptide Hormones, Stimulants, Nootropics, Beta-2 Agonists); By Application (Athletic Performance, Bodybuilding & Aesthetics, Cognitive Enhancement); By Distribution Channel (Prescription-Based, OTC Supplements, Black/Grey Market); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Performance Enhancing Drugs Market is estimated to reach $19.1 billion in 2024 and is projected to grow steadily to $27.6 billion by 2030, with a CAGR of 6.3%Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Glycinates Market By Product Type (Magnesium Glycinate, Zinc Glycinate, Calcium Glycinate, Iron Glycinate, Copper Glycinate, Manganese Glycinate); By Application (Animal Feed, Dietary Supplements, Pharmaceuticals, Personal Care); By End User (Feed Manufacturers, Nutraceutical Companies, Pharmaceutical Companies, Cosmetic Brands); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glycinates Market is projected to grow steadily at an estimated CAGR of 5.3%, reaching around USD 1.34 billion by 2030, ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Macrolide Antibiotics Market By Drug Type (Erythromycin, Azithromycin, Clarithromycin, Others); By Application (Respiratory Tract Infections, Skin and Soft Tissue Infections, Sexually Transmitted Infections, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Macrolide Antibiotics Market is poised for measured yet steady growth between 2024 and 2030, according to Strategic Market Research . The market, valued at USD 4.8 billion in 2024<... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Oxytocic Pharmaceuticals Market By Drug Type (Oxytocin, Misoprostol, Carbetocin, Ergometrine); By Route of Administration (Injectable, Oral, Sublingual/Buccal/Rectal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Government & NGO Supply Chains); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oxytocic Pharmaceuticals Market is projected to grow at a steady CAGR of 5.6% , reaching approximately USD 257.4 million by 2030 , up from an estimated Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Thr-β Agonist Market By Fibrosis Stage (F2, F3); By Diagnosis Pathway (Biopsy-Confirmed, NIT-Confirmed); By Treatment Setting (Monotherapy, Combination Therapy); By Geography, Segment Revenue Estimation, Forecast, 2025–2035

INTRODUCTION AND STRATEGIC CONTEXT

The Global Thr-β Agonist Market is set to expand rapidly between 2025 and 2035, growing from under $1 billion in 2025 to nearly $11 billion by 2030, according to Strategic Marke... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Integrase Inhibitors Market By Product Type (Oral Tablets, Combination Tablets, Long-Acting Injectables); By Application (First-Line Therapy, Treatment-Experienced Patients, Prophylaxis); By End User (Hospitals, HIV Care Centers, Outpatient Clinics, Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Integrase Inhibitors Market is projected to grow at a robust CAGR of 9.1 %, with an estimated market value of USD 12.3 billion in... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Anthelmintic Drugs Market By Product Type (Benzimidazoles, Macrocyclic Lactones, Imidazothiazoles, Others); By Route of Administration (Oral, Injectable, Topical); By End User (Hospitals/Clinics, Public Health Programs, Livestock Farms, Poultry & Aquaculture, Companion Animal Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anthelmintic Drugs Market is projected to witness a steady growth trajectory, with an CAGR of 5.8%, valued at USD 4.2 billion in 2024, and expected to reach USD 6.... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

VMAT2 Inhibitors Market by Application (Parkinson’s Disease, Huntington’s Disease, Tardive Dyskinesia, Other Neurological Disorders); By End User (Hospitals, Specialty Clinics, Outpatient Care Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global VMAT2 Inhibitors Market is set to grow significantly, driven by advancements in neurological therapeutics and an increasing understanding of neurological disorders. As of 2024, the market ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Alkylating Agents Market By Product Type (Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazenes, Others); By Route of Administration (Intravenous, Oral); By Application (Hematological Malignancies, Solid Tumors, Others); By End User (Hospitals, Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alkylating Agents Market is projected to witness a robust CAGR of 6.4%, valued at USD 7.1 billion in 2024, and expected to reach USD 10.4 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Povidone Iodine Market By Product Type (Scrub Solution, Ointment, Gargle, Swabs, Others); By Formulation (Liquid, Powder, Ointment, Spray); By Application (Wound Care, Surgical Disinfection, Oral Care, Gynecological Hygiene, Dermatology); By End User (Hospitals, Clinics, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Povidone Iodine Market is projected to reach approximately USD 920 million by 2030, growing from an estimated USD 640 million in 2024, at a steady Read More

Published Date: JAN-2026 | No Of Pages:200 | $ 4485

Cannabis Pharmaceuticals Market By Product Type (Cannabidiol [CBD], Tetrahydrocannabinol [THC], Combination Cannabinoids, Synthetic Cannabinoids); By Route of Administration (Oral, Inhalation, Topical, Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cannabis Pharmaceuticals Market is poised to expand at a CAGR of 17.6%, with a valuation of approximately USD 3.9 billion in 2024, expected to reach Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

WNT Signaling Pathway Inhibitor Market By Type of Inhibitor (Small Molecule Inhibitors, Monoclonal Antibodies, Other Biologics); By Application (Oncology, Bone Diseases, Neurodegenerative Diseases); By End-User (Hospitals, Research Institutions, Specialized Cancer Centers, Diagnostic Laboratories); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global WNT Signaling Pathway Inhibitor Market is poised to experience significant growth, driven by increasing demand for targeted therapies and advancements in cancer treatment. Valued at approx... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Peptide and Anticoagulant Drugs Market By Product Type (Peptide-based Therapies, Anticoagulants); By Application (Cardiovascular, Oncology, Neurology, Endocrine & Metabolic Disorders); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers [ASCs], Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Peptide And Anticoagulant Drugs Market is set to experience robust growth, with an expected compound annual growth rate (CAGR) of 6.5% fr... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Vaginal Anti-Infectives Market By Product Type (Antifungal Agents, Antibacterial Formulations, Antiseptics, Probiotic-Based Products); By Infection Type (Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis, Mixed Infections); By Route of Administration (Topical, Oral, Vaginal Tablets & Suppositories); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vaginal Anti-Infectives Market is projected to grow steadily between 2024 and 2030, expanding from an estimated value of USD 3.1 billion in 2024 to nearly USD 4.6 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Uterotonic Agent Market By Product Type (Oxytocin-Based, Prostaglandins, Ergot Derivatives, Combination Therapies); By Route of Administration (Intravenous, Intramuscular, Oral, Sublingual); By End User (Hospitals, Maternity Clinics & Birthing Centers, Community Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Uterotonic Agent Market will witness a robust CAGR of 6.8 %, valued at USD 2.1 billion in 2024, and is ... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Sulfonylureas Market By Drug Generation (First-Generation, Second-Generation); By Application (Type 2 Diabetes Mellitus, Obesity-linked Diabetes, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sulfonylureas Market is projected to reach approximately USD 2.5 billion in 2024 , with expectations to touch USD 3.1 billion by 2030 , reflecting a Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Neuraminidase Inhibitors Market By Product Type (Oseltamivir, Zanamivir, Peramivir, Next-Generation Long-Acting Inhibitors); By Route of Administration (Oral, Inhalation, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Government Supply Programs); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Neuraminidase Inhibitors Market is projected to expand steadily between 2024 and 2030, witnessing a CAGR of 6.8% , valued at USD 4.6 billion in 2024 and expected to reach ... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Mitotic Inhibitors Market By Drug Class (Vinca Alkaloids, Taxanes, Others); By Application (Breast Cancer, Lung Cancer, Ovarian Cancer, Leukemia & Lymphoma, Other Solid Tumors); By Route of Administration (Intravenous, Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitotic Inhibitors Market is projected to expand at a CAGR of 5.9% , with an estimated valuation of USD 3.1 billion in 2024 , expected to reach around Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Meglitinides Market By Molecule Type (Repaglinide, Nateglinide); By Formulation (Monotherapy Tablets, Fixed-Dose Combinations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Meglitinides Market is projected to reach USD 754 million by 2030 , up from an estimated USD 520 million in 2024 , growing at a C... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Leukotriene Inhibitors Market By Drug Type (Montelukast, Zafirlukast, Pranlukast, Others); By Application (Asthma, Allergic Rhinitis, Chronic Urticaria, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leukotriene Inhibitors Market is projected to grow at a steady pace, rising from an estimated USD 1.62 billion in 2024 to approximately USD 2.31 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Keratolytic Agents Market By Product Type (Salicylic Acid, Urea, Alpha Hydroxy Acids, Lactic Acid, Sulfur Compounds, Others); By Formulation Type (Topical Creams & Ointments, Gels & Serums, Medicated Shampoos, Patches & Plasters, Liquid Solutions & Peels); By Application (Dermatological Disorders, Cosmetic Exfoliation & Skincare, Wart & Callus Removal, Foot Care, Scalp and Hair Treatment, Veterinary & Niche Use); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Keratolytic Agents Market is projected to expand at a CAGR of 5.8% , rising from an estimated $1.12 billion in 2024 to reach approximately $1.58 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:198 | $ 4485

Inactivated Vaccines Market By Vaccine Type (Whole Virus Inactivated, Split/Subunit, Toxoid); By Indication (Polio, Hepatitis A, Rabies, Influenza, Combination Vaccines); By End User (Public Health Programs, Pediatric Clinics, Travel Clinics, Military & Occupational Health); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inactivated Vaccines Market is projected to grow at a steady CAGR of 6.8% between 2024 and 2030. Estimated at around USD 22.7 billion in 2024, the market ... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Aldose Reductase Inhibitor Market By Drug Type (Epalrestat, Ranirestat, Fidarestat, Investigational ARIs); By Application (Diabetic Neuropathy, Diabetic Retinopathy, Diabetic Nephropathy, Others); By Route of Administration (Oral, Topical, Injectable); By End User (Hospitals, Specialty Clinics, Diabetic Care Centers, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aldose Reductase Inhibitor Market will witness a steady CAGR of 7.9%, valued at USD 610.0 million in 2024, and expected to reach around <... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Inotropic Agents Market By Drug Type (Positive Inotropes, Negative Inotropes); By Route of Administration (Intravenous, Oral); By Application (Heart Failure, Cardiogenic Shock, Myocardial Infarction, Perioperative Cardiac Support); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Inotropic Agents Market is projected to witness a steady expansion between 2024 and 2030, growing at an CAGR of 5.8%. The market, valued at around USD 2.9 billion ... Read More

Published Date: JAN-2026 | No Of Pages:191 | $ 4485

Incretin Mimetics Market By Drug Class (GLP-1 Receptor Agonists, Dual Incretin Agonists [GLP-1/GIP], Triple Agonists [GLP-1/GIP/Glucagon]); By Route of Administration (Injectable, Oral); By Application (Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, NASH & Metabolic Disorders); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Incretin Mimetics Market is projected to experience steady expansion between 2024 and 2030, according to Strategic Market Research . The market is valued at approximately USD 18.6 ... Read More

Published Date: JAN-2026 | No Of Pages:184 | $ 4485

Glycopeptide Antibiotics Market By Product Type (Vancomycin, Teicoplanin, Lipoglycopeptides [Dalbavancin, Oritavancin, Telavancin]); By Route of Administration (Intravenous, Oral); By Indication (MRSA Infections, CDI, Bloodstream & Sepsis, SSTIs, Bone & Joint Infections); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Glycopeptide Antibiotics Market is projected to grow steadily at an estimated CAGR of 6.1% , reaching approximately USD 3.2 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Gemcitabine Hydrochloride (Gemcitabine HCl) Market By Product Type (Branded Gemcitabine, Generic Gemcitabine); By Route of Administration (Intravenous Infusion, Experimental Delivery Systems); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gemcitabine Hydrochloride Market is expected to reach USD 2.84 billion by 2030 , up from an estimated USD 1.92 billion in 2024 , expanding at a CA... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Lung Surfactants Market By Type (Natural Surfactants, Synthetic Surfactants); By Delivery Method (Intratracheal Instillation, LISA, Nebulized/Aerosolized); By Application (Neonatal RDS, Meconium Aspiration Syndrome, Pulmonary Hemorrhage, Adult ARDS); By End User (Tertiary Hospitals, General Hospitals, Private Maternity Clinics, Government/NGO Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lung Surfactants Market is expected to expand at a steady CAGR of 6.9%, reaching an estimated size of USD 1.78 billion by 2030, up from USD 1.19 billion in 2024Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Endothelin Antagonists Therapeutics Market By Drug Type (Selective ETA Antagonists, Dual ETA/ETB Antagonists); By Application (Pulmonary Arterial Hypertension [PAH], Chronic Kidney Disease & Diabetic Nephropathy, Systemic Sclerosis and Fibrosis Disorders); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Endothelin Antagonists Therapeutics Market is projected to grow steadily at a CAGR of 6.8%, valued at USD 2.3 billion in 2024 and anticipated to reach Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Cell Cycle Inhibitors Market By Drug Class (CDK4/6 Inhibitors, Aurora Kinase Inhibitors, WEE1 Inhibitors, CHK1/2 Inhibitors, Multi-Target Inhibitors); By Cancer Type (Breast Cancer, Lung Cancer, Ovarian Cancer, Glioblastoma, Hematologic Malignancies, Others); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cell Cycle Inhibitors Market is poised for steady expansion, expected to register a CAGR of 6.8%, rising from an estimated USD 5.3 billion in 2024 to appr... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Mitogen-Activated Protein Kinase (MAPK) Inhibitors Market By Inhibitor Type (BRAF Inhibitors, MEK Inhibitors, ERK Inhibitors, Multi-Kinase Inhibitors); By Application (Oncology, Inflammatory Disorders, Rare Genetic Syndromes); By Route of Administration (Oral, Intravenous); By End User (Hospitals & Oncology Centers, Academic & Research Institutions, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitogen - Activated Protein Kinase ( MAPK ) Inhibitors Market will witness a robust CAGR of 9.8... Read More

Published Date: JAN-2026 | No Of Pages:194 | $ 4485

Antiplatelet Drugs Market By Product Type (Aspirin, Thienopyridines, P2Y12 Inhibitors, Combination Therapies); By Route of Administration (Oral, Injectable); By End User (Hospitals, Cardiology Clinics, Retail Pharmacies & Online Platforms, Specialized Cardiovascular Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiplatelet Drugs Market will witness a robust CAGR of 6.5%, valued at USD 15.2 billion in 2024, and expected to appreciate and reach USD 22.5 billion by 2030,Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Fibroblast Activation Protein (FAP) Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Antibody-Based Inhibitors, Radiopharmaceutical Conjugates); By Therapeutic Indication (Oncology, Fibrotic Diseases); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Cancer and Specialty Hospitals, Academic & Research Institutions, Diagnostic Imaging Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Fibroblast Activation Protein (FAP) Inhibitors Market is estimated to be valued at USD 820 million in 2024 and is projected to reach around USD 1.45 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:169 | $ 4485

Fibrate Drugs Market By Drug Type (Fenofibrate, Gemfibrozil, Bezafibrate, Ciprofibrate, Pemafibrate); By Route of Administration (Oral, Parenteral [Experimental]); By Indication (Hypertriglyceridemia, Mixed Dyslipidemia, Cardiovascular Disease Prevention); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibrate Drugs Market is projected to witness steady expansion between 2024 and 2030, growing at an CAGR of 5.8% , valued at USD 2.9 billion in 2024 and expected to reach a... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Eye Drops and Lubricants Drugs Market By Product Type (Artificial Tears, Lipid-Based Lubricants, Anti-inflammatory Eye Drops, Preservative-Free Formulations, Nanoemulsion-Based Systems); By Therapeutic Indication (Dry Eye, Post-Surgical Recovery, Allergic Conjunctivitis, Meibomian Gland Dysfunction, Contact Lens Discomfort); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Eye Drops And Lubricants Drugs Market is projected to grow at a steady CAGR of 7.1% , reaching approximately USD 6.2 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Expectorant Drugs Market By Drug Type (Synthetic Expectorants, Natural/Herbal Expectorants); By Formulation (Syrup, Tablet, Capsule, Extended-Release); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By End User (Hospitals, Clinics, Homecare Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Expectorant Drugs Market is projected to grow at a steady CAGR of around 5.8% , valued at USD 7.9 billion in 2024 and anticipated to reach nearly USD 11.1 billion ... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Cough Suppressant Market By Product Type (Pharmaceutical-based, Herbal/Natural, Combination); By Route of Administration (Syrups, Lozenges, Capsules, Sprays); By Age Group (Pediatrics, Adults, Geriatrics); By Distribution Channel (Retail Pharmacies, Online Platforms, Hospitals & Clinics, Wellness Stores); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cough Suppressant Market is projected to grow at a CAGR of 5.8% between 2024 and 2030, reaching an estimated value of around USD 9.7 billion by 2030 , up ... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Cephalosporin Drugs Market By Generation (First, Second, Third, Fourth, Fifth); By Route of Administration (Oral, Parenteral); By Application (Respiratory, Skin & Soft Tissue, Urinary Tract, Gastrointestinal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cephalosporin Drugs Market is projected to grow steadily at a CAGR of 4.9% between 2024 and 2030 , with an estimated valuation of USD 15.6 billion... Read More

Published Date: JAN-2026 | No Of Pages:196 | $ 4485

Calcium Channel Blocker Market By Drug Class (Dihydropyridines, Non-Dihydropyridines); By Application (Hypertension, Angina, Arrhythmias, Others); By End User (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Calcium Channel Blocker Market will witness a robust growth rate, valued at USD 8.7 billion in 2024, and is expected to reach USD 12.1 billion by 2030, confirming a CAGR ... Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Calcimimetics Market By Drug Type (Cinacalcet, Etelcalcetide, Others); By Indication (Secondary Hyperparathyroidism, Primary Hyperparathyroidism, Parathyroid Carcinoma, Others); By Route of Administration (Oral, Intravenous); By End User (Dialysis Centers, Hospitals, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcimimetics Market is forecast to grow at a steady CAGR of 6.1% , rising from approximately USD 872.5 million in 2024 to reach an estim... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Bone Resorption Inhibitors Market By Product Type (Bisphosphonates, Selective Estrogen Receptor Modulators [SERMs], Calcitonin, Monoclonal Antibodies); By Route of Administration (Oral, Parenteral [Subcutaneous, Intravenous]); By Application (Osteoporosis, Oncology-related Bone Disease, Rheumatologic Disorders, Endocrine-related Bone Loss); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Ambulatory Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Bone Resorption Inhibitors Market is projected to grow steadily through 2024–2030, advancing at an estimated CAGR of 5.8% . The market, valued around USD 11.2 billion in 2024... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Benzodiazepine Drugs Market By Drug Type (Short-Acting, Long-Acting); By Application (Anxiety, Insomnia, Seizures, Alcohol Withdrawal, Preoperative Sedation); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benzodiazepine Drugs Market is expected to grow at a CAGR of 3.9% , reaching an estimated value of USD 4.3 billion in 2024 and projected to reach approxim... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Bacterial Vaccines Market By Vaccine Type (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Subunit & Recombinant Vaccines); By Disease Indication (Pneumococcal, Pertussis, Meningococcal, Tuberculosis, Typhoid & Cholera, Others); By Route of Administration (Injectable, Oral, Intranasal); By End User (Hospitals & Clinics, Vaccination Centers, Travel & Occupational Health Providers, Government Immunization Programs, NGOs & Multilateral Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bacterial Vaccines Market will witness a robust CAGR of 8.6%, valued at USD 25.6 billion in 2024 , and is expected to reach USD 42.1 billion by 2030 , acc... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Anxiolytics Market By Drug Class (Benzodiazepines, SSRIs, SNRIs, Azapirones [Buspirone], Antihistamines, Others [Neurosteroids, Cannabinoid-Based Compounds]); By Application (Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Post-Traumatic Stress Disorder [PTSD], Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies & Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anxiolytics Market is projected to expand at an CAGR of 5.7% , valued at around USD 14.8 billion in 2024 and anticipated to reach USD 20.6 billion by 2030... Read More

Published Date: JAN-2026 | No Of Pages:151 | $ 4485

Antivertigo Agents Market By Drug Class (Antihistamines, Anticholinergics, Benzodiazepines, Beta Blockers & Calcium Channel Blockers, Others); By Route of Administration (Oral, Transdermal, Injectable, Intranasal & Sublingual); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antivertigo Agents Market is estimated to reach USD 2.7 billion in 2024 , and is projected to grow to USD 3.9 billion by 2030 , expanding... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Antitussive Drugs Market By Drug Type (Opioid-Based, Non-Opioid); By Formulation (Syrup, Tablets & Capsules, Lozenges & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antitussive Drugs Market is projected to expand at an estimated CAGR of 4.8% , reaching around USD 6.9 billion by 2030 , up from approximately USD... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Antithyroid Agents Market By Drug Type (Methimazole, Propylthiouracil, Carbimazole); By Route of Administration (Oral, Liquid Formulations); By Disease Indication (Graves’ Disease, Toxic Multinodular Goiter, Thyroid Adenoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antithyroid Agents Market is estimated to be valued at USD 1.4 billion in 2024 , expected to reach USD 1.9 billion by 2030 , growing at a CAGR of around 5.1%Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Antispasmodics Drugs Market By Drug Class (Smooth Muscle Relaxants, Anticholinergics, Combination Therapies); By Application (Gastrointestinal Disorders, Urinary Tract Disorders, Menstrual Pain, Neuromuscular Spasms); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antispasmodics Drugs Market is projected to grow steadily at a CAGR of 5.6% , valued at USD 3.8 billion in 2024 and expected to reach nearly USD 5.3 billion by 203... Read More

Published Date: JAN-2026 | No Of Pages:166 | $ 4485

Antifibrinolytic Drugs Market By Drug Type (Tranexamic Acid, Aminocaproic Acid, Others); By Route of Administration (Intravenous, Oral, Topical/IM); By End User (Hospitals & Surgical Centers, EMS, Maternal Health Clinics, Outpatient Gynecology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antifibrinolytic Drugs Market is projected to reach approximately USD 2.6 billion by 2030 , up from an estimated USD 1.8 billion in 2024 ... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Antidotes Market By Product Type (Chemical Antidotes, Drug Overdose Antidotes, Biological/Enzymatic Antidotes); By Route of Administration (Intravenous, Oral, Intramuscular); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Emergency Supply Chains); By End User (Hospitals, Poison Control Centers, EMS, Military/Disaster Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antidotes Market will witness a robust CAGR of 6.8 %, valued at an estimated USD 4.2 billion in 2024 , expected to reach... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Antiretroviral Therapy Market By Drug Class (NRTIs, NNRTIs, INSTIs, Protease Inhibitors, Entry Inhibitors); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online, Public Supply); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiretroviral Therapy Market is estimated to reach USD 34.7 billion in 2024 and is projected to expand to nearly USD 51.9 billion by 2030, reflecting a CAGR of 6.... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Vinblastine Sulfate Market By Product Type (Generic, Branded); By Route of Administration (Injectable, Oral [Exploratory]); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online/Institutional Procurement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vinblastine Sulfate Market is projected to grow at a CAGR of 5.8%, valued at USD 145.0 million in 2024,... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Cerumenolytic Agents Market By Product Type (Oil-Based Agents, Water-Based Agents, Non-Water/Non-Oil Agents); By Route of Administration (Ear Drops, Sprays, Irrigation Kits); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By End User (Hospitals, ENT Clinics, Households); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cerumenolytic Agents Market will witness a steady CAGR of 5.8%, valued at USD 1.6 billion in 2024, and projected to reach USD 2.2 billion by 2030, accordi... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Anticonvulsants Market By Drug Class (Barbiturates, Benzodiazepines, Hydantoins, Succinimides, Carbonic Anhydrase Inhibitors, Others); By Route of Administration (Oral, Intravenous, Nasal, Transdermal); By Indication (Epilepsy, Neuropathic Pain, Bipolar Disorder, Fibromyalgia, Migraine); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anticonvulsants Market will witness a stable CAGR of 5.95%, valued at USD 22.8 billion in 2024, and projected to reach USD 32.4 billion by 2030, according... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Ipilimumab Market By Product Type (Monotherapy, Combination Therapy); By Application (Melanoma, Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ipilimumab Market will witness a steady CAGR of 8.1%, valued at USD 5.2 billion in 2024 and projected to reach USD 8.3 billion by... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Thymidylate Synthase Inhibitor Market By Drug Type (5-Fluorouracil, Capecitabine, Pemetrexed, Other Thymidylate Synthase Inhibitors); By Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Other Cancers); By End User (Hospitals, Oncology Clinics, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Research & Academic Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thymidylate Synthase Inhibitor Market is expected to experience significant growth between 2024 and 2030, with a projected compound annual growth rate (CAGR) of 7.5%. The ... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Adrenocorticotropic Hormone Market By Product Type (Natural ACTH, Synthetic ACTH Analogs); By Indication (Infantile Spasms, Multiple Sclerosis, Nephrotic Syndrome, Other Rare Indications); By Route of Administration (Intramuscular, Subcutaneous, Extended-Release/Depot); By End User (Hospitals & Tertiary Care, Specialty Clinics, Home Care & Specialty Pharmacy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Adrenocorticotropic Hormone Market will witness a steady CAGR of 5.9%, valued at $1.17 billion in 2024, and projected to reach $1.66 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Lincomycin Market By Product Form (Injection, Capsule, Granule/Powder); By Application (Human Therapeutics, Veterinary Medicine, Industrial Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lincomycin Market will witness a moderate yet steady CAGR of around 5.6%, valued at USD 1.2 billion in 2024, and projected to reach nearly USD 1.7 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Appetite Stimulant Market By Product Type (Pharmaceuticals, Natural Supplements, Over-the-Counter Products); By Application (Cancer, Neurological Disorders, Chronic Diseases, Anorexia & Other Conditions); By End User (Hospitals & Clinics, Homecare, Long-Term Care Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Appetite Stimulant Market will witness a robust CAGR of 6.4%, valued at USD 4.3 billion in 2024, expected to appreciate and reach USD 6.5 billion<... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Cardioselective Beta Blockers Market By Drug Type (Metoprolol, Bisoprolol, Atenolol, Nebivolol, Others); By Application (Hypertension, Angina & Ischemic Heart Disease, Arrhythmias, Heart Failure, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies, Public Health Programs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardioselective Beta Blockers Market is projected to grow steadily, reaching an estimated USD 6.8 billion in 2024 and expanding to around USD 9.5 ... Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Cardiovascular Drugs Market By Therapeutic Class (Antihypertensives, Statins, Anticoagulants, Antiplatelets, Biologics & RNA-based Drugs); By Application (Hypertension, Hyperlipidemia, Coronary Artery Disease, Heart Failure, Arrhythmias, Thrombosis); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online/Mail-Order Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiovascular Drugs Market is projected to expand steadily at a CAGR of 5.6%, reaching an estimated value of USD 155.2 billion in 2024 and projected to h... Read More

Published Date: JAN-2026 | No Of Pages:158 | $ 4485

Sedative-Hypnotic Drugs Market by Drug Type (Benzodiazepines, Non-Benzodiazepine Sleep Aids, Barbiturates, Melatonin Receptor Agonists, Other Sedative-Hypnotics); By Application (Sleep Disorders, Anxiety Disorders, Severe Mental Health Disorders); By End User (Hospitals, Outpatient Clinics, Pharmacies, Research Institutions); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sedative-Hypnotic Drugs Market is projected to reach USD 5.8 billion in 2024 and is expected to grow at a CAGR of 5.8% from 2024 to 2030, reaching an esti... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Orexin Receptor Antagonist Market By Drug Type (Dual Orexin Receptor Antagonists, Selective Orexin Receptor Antagonists); By Application (Insomnia, Narcolepsy, Anxiety & Depression-Related Sleep Disorders, PTSD); By Route of Administration (Oral, Sublingual Film, Liquid Suspension, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orexin Receptor Antagonist Market is on a sharp upward trajectory. It’s estimated to be worth $2.6 billion in 2024 and is projected to reach $ 6.52 ... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Ovulation Inducing Drugs Market By Drug Type (Clomiphene Citrate, Aromatase Inhibitors, Gonadotropins, Dopamine Agonists, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ovulation Inducing Drugs Market is projected to expand steadily, with an estimated value of USD 4.7 billion in 2024 and expected to reach USD 6.9 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:182 | $ 4485

Topical Antibiotics Market By Product Type (Mupirocin, Fusidic Acid, Neomycin & Bacitracin, Clindamycin & Erythromycin, Others); By Formulation (Ointments & Creams, Gels & Lotions, Eye/Ear Drops, Powders & Sprays); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Topical Antibiotics Market will grow steadily between 2024 and 2030, advancing at a CAGR of 5.9%, valued at approximately USD 4.6 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Erythropoietin Stimulating Agents (ESA) Market By Drug Type (Biologics, Biosimilars); By Application (Chronic Kidney Disease, Oncology-Associated Anemia, HIV & Other Indications); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Erythropoietin Stimulating Agents (ESA) Market is projected to grow steadily between 2024 and 2030. It is valued at an estimated ... Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Allergy Vaccine Market By Allergy Type (Pollen, Dust Mite, Animal Dander, Food Allergens, Insect Venom); By Route of Administration (Subcutaneous, Sublingual, Oral); By End User (Allergy Clinics, Hospitals, Pediatric Clinics, Retail Pharmacies, Telemedicine Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allergy Vaccine Market is projected to register a steady CAGR of 8.4% , reaching an estimated value of USD 2.6 billion in 2024 , and is on track to surpass USD 4.2... Read More

Published Date: JAN-2026 | No Of Pages:154 | $ 4485

Nexletol Market By Drug Type (Monotherapy, Combination Therapy); By Therapeutic Application (ASCVD, HeFH); By End User (Cardiology Clinics, Hospitals, Primary Care, Pharmacies); By Distribution Channel (Specialty Pharmacies, Retail Pharmacies, Hospital Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nexletol Market will witness a robust CAGR of 14% , valued at $1.2 billion in 2024 and expected to reach around $2.7 billion by 2... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Tamoxifen Market By Product Type (Oral Tablet, Liquid Formulation, Compounded Formulation); By Application (Adjuvant Therapy, Metastatic Breast Cancer, Risk Reduction/Prevention); By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online/Specialty Pharmacy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tamoxifen Market is on track to post a steady CAGR of 6.1 % , standing at an estimated value of USD 700 million in 2024 and forecast to reach close to Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Etanercept Market By Indication (Rheumatoid Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Juvenile Idiopathic Arthritis, Others); By Route of Administration (Prefilled Syringe, Autoinjector Pen, Others); By End User (Specialty Pharmacies, Hospital Pharmacies, Retail Pharmacies, Home Delivery Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Etanercept Market is projected to register a steady CAGR of 4.5% , reaching a valuation of $20.1 billion in 2024 , with expectations to touch $26.1 billion by 2030... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Pharmaceutical Solvents Market By Type (Polar Solvents, Non-Polar Solvents, Co-Solvents); By Application (API Synthesis, Formulation & Excipients, Analytical Testing, Specialty Applications); By End User (Pharmaceutical Manufacturers, Biopharmaceutical Companies, CROs/CMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pharmaceutical Solvents Market will witness a robust CAGR of 6.1% , valued at USD 12.8 billion in 2024 , expected to appreciate and reach USD 18.5 billion by 2030<... Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Alkaloid Based Drugs Market By Product Type (Analgesics, Antimalarials, Anticancer Alkaloids, Cardiovascular Alkaloids, Others); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Alkaloid Based Drugs Market will witness a steady CAGR of around 6.1%, valued at USD 38.5 billion in 2024 , and is projected to reach nearly USD 5... Read More

Published Date: JAN-2026 | No Of Pages:171 | $ 4485

Radionuclide Injection Market By Radionuclide Type (Diagnostic Isotopes [Technetium-99m, Fluorine-18, Iodine-123], Therapeutic Isotopes [Lutetium-177, Yttrium-90, Actinium-225, Others]); By Application (Oncology, Cardiology, Neurology, Others); By End User (Hospitals & Cancer Centers, Diagnostic Imaging Centers, Academic & Research Institutes, Outpatient Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radionuclide Injection Market will witness a steady CAGR of 6.4%, valued at around USD 1.2 billion in 2024, and projected to reach nearly USD 1.9 billion by 2030,<... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Pingueculum Drugs Market By Drug Class (Corticosteroids, Artificial Tears, Immunomodulators, Lubricants, Others); By Route of Administration (Topical, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pingueculum Drugs Market is set to grow at an CAGR of 4.7%, reaching an estimated USD 203 million in 2024 and projected to hit US... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

GRDDS (Gastroretentive Drug Delivery Systems) Outsourcing Market By Delivery System Type (Floating Drug Delivery Systems, Mucoadhesive Systems, High-Density Systems, Expandable Systems, Superporous Hydrogel Systems); By Drug Type (Branded Drugs, Generic Drugs); By Outsourcing Type (Formulation Development, Process Optimization and Scale-Up, Analytical Testing and Regulatory Filing, Manufacturing and Packaging); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GRDDS (Gastroretentive Drug Delivery Systems) Outsourcing Market is set to expand at a robust CAGR of 9.7%, from USD 1.43 billion in ... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Vasoconstrictor Drugs Market By Drug Class (Adrenergic Agonists, Non-Catecholamine Vasopressors, Topical Vasoconstrictors, Emerging Agents); By Application (Critical Care & Shock Management, Surgical & Perioperative Use, ENT & Ophthalmic Procedures, Migraine & Neurological Disorders); By Route of Administration (Injectable, Topical & Nasal, Oral & Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vasoconstrictor Drugs Market is projected to expand at a CAGR of 5.8%, valued at USD 2.9 billion in 2024 and anticipated to reach USD 4.1 billion by 2030,... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Empagliflozin, Dapagliflozin, and Canagliflozin Market By Drug Type (Empagliflozin, Dapagliflozin, Canagliflozin); By Application (Type 2 Diabetes, Heart Failure, Chronic Kidney Disease, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Empagliflozin , Dapagliflozin , And Canagliflozin Market is set to expand at an estimated CAGR ... Read More

Published Date: JAN-2026 | No Of Pages:195 | $ 4485

Antiseptics and Disinfectant Market By Product Type (Surface Disinfectants, Hand/Skin Antiseptics, Others); By Formulation (Liquids, Wipes, Foams, Concentrates); By Application (Healthcare, Food Processing, Hospitality, Transportation, Education, Consumer); By End User (Hospitals, Clinics, Long-Term Care, Households, Food/Bev, Public Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antiseptics And Disinfectant Market is poised for steady expansion, with an CAGR of 6.3% , reaching an estimated value of USD 7.8 billion in 2024 and proj... Read More

Published Date: JAN-2026 | No Of Pages:186 | $ 4485

Calcineurin Inhibitors Market By Drug Type (Tacrolimus, Cyclosporine, Others); By Route of Administration (Oral, Topical, Intravenous); By Application (Organ Transplantation, Autoimmune Diseases, Dermatology, Ophthalmology); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Calcineurin Inhibitors Market is projected to reach USD 4.6 billion by 2030 , up from an estimated USD 3.2 billion in 2024 , expanding at... Read More

Published Date: JAN-2026 | No Of Pages:168 | $ 4485

Dyspepsia Drugs Market By Product Type (Proton Pump Inhibitors, H2 Receptor Antagonists, Antacids, Prokinetics, Combination Therapies); By Route of Administration (Oral, Injectable, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dyspepsia Drugs Market will expand at a CAGR of 5.1%, valued at USD 8.7 billion in 2024 and projected to reach USD 11.7 billion by 2030, confirms ... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Serine Amino Acid Market By Product Type (L-Serine, D-Serine, DL-Serine); By Application (Pharmaceuticals & Biotechnology, Food & Dietary Supplements, Cosmetics & Personal Care, Animal Feed & Nutrition); By End User (Pharmaceutical Companies & Research Institutes, Food & Nutraceutical Brands, Cosmetic Manufacturers, Animal Feed Producers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Serine Amino Acid Market is projected to expand steadily over the forecast period, advancing at an estimated CAGR of 5.8%, from around USD 220.0 m... Read More

Published Date: JAN-2026 | No Of Pages:193 | $ 4485

Vitamin A-Acetate Market By Formulation (Dry Powder/Beadlets, Oil Form, Emulsified/Encapsulated); By Application (Food & Beverages, Dietary Supplements, Pharmaceuticals, Cosmetics & Personal Care, Animal Nutrition); By Distribution Channel (Direct Supply, Retail & E-commerce); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vitamin A - Acetate Market is projected to expand steadily, with an estimated value of USD 780.0 Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Hypolipidemic Drugs Market By Drug Type (Statins, PCSK9 Inhibitors, Bempedoic Acid, Omega-3 Derivatives, Fibrates & Niacin); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online/Mail-Order); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hypolipidemic Drugs Market is projected to grow at a CAGR of 6.4%, rising from an estimated USD 35.6 billion in 2024 to approximately Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Tetracycline Market By Product Type (Tetracycline, Doxycycline, Minocycline, Others); By Application (Respiratory Infections, UTIs, STIs, Acne and Skin Disorders, Periodontal Infections, Vector-Borne Diseases); By End User (Hospitals & Clinics, Retail Pharmacies, Online Pharmacies, Veterinary Clinics, Livestock & Poultry Farms); By Route of Administration (Oral, Parenteral, Topical); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tetracycline Market is projected to expand at a steady CAGR of 5.4%, valued at roughly USD 12.6 billion in 2024 and expected to reach Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Nephrology Drugs Market By Drug Class (ACE Inhibitors/ARBs, SGLT2 Inhibitors, Phosphate Binders, ESAs, Diuretics, Immunosuppressants, Others); By Indication (Chronic Kidney Disease, Acute Kidney Injury, Glomerulonephritis, Nephrotic Syndrome, Polycystic Kidney Disease, Others); By Route of Administration (Oral, Intravenous, Subcutaneous, Inhaled); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nephrology Drugs Market will witness a moderate but steady CAGR of 5.6%, valued at around $19.8 billion in 2024, and is anticipated to reach $27.5 billion by 2030<... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Constrained Peptide Drugs Market By Product Type (Natural Constrained Peptides, Synthetic Constrained Peptides, Modified Peptides [Stapled, Cyclic]); By Application (Oncology, Autoimmune Disorders, Infectious Diseases, Metabolic Disorders); By Route of Administration (Parenteral, Oral, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Constrained Peptide Drugs Market will witness a strong CAGR of around 10.6%, valued at approximately USD 4.9 billion in 2024, expected to expand and reach USD 9.0 ... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Oral Expectorant Market By Product Type (Guaifenesin-based Expectorants, Natural and Herbal Expectorants, Combination Expectorants); By Application (Bronchitis and Respiratory Infections, Chronic Respiratory Diseases, Cold and Flu); By End User (Over-the-Counter (OTC), Prescription, Hospitals and Clinics, Retail Pharmacies and Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Oral Expectorant Market will witness a robust CAGR of approximately 5.2%, valued at USD 4.1 billion in 2024, and expected to reach Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

P2X7 Receptor Antagonists Market By Product Type (Oral Small Molecules, Injectable Biologics, Others); By Application (Rheumatoid Arthritis, Neuropathic Pain, Inflammatory Bowel Disease, ALS, Alzheimer’s Disease, Others); By End User (Hospitals, Specialty Clinics, Community Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global P2X7 Receptor Antagonists Market will witness a robust CAGR of 8.1%, valued at USD 614.5 million in 2024, and is expected to reach Read More

Published Date: JAN-2026 | No Of Pages:165 | $ 4485

Metoprolol Tartrate Market By Formulation (Oral, Injectable); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Metoprolol Tartrate Market is set for steady expansion, with an estimated value of USD 2.6 billion in 2024 and a projected increase to nearly USD 3.5 billion by 2030, refl... Read More

Published Date: JAN-2026 | No Of Pages:180 | $ 4485